Scancell (LON:SCLP) Trading Down 8.9% – Here’s What Happened

Scancell Holdings plc (LON:SCLP)’s stock price traded down 8.9% on Monday . The company traded as low as GBX 7.72 ($0.10) and last traded at GBX 7.72 ($0.10). 395,448 shares were traded during mid-day trading, a decline of 51% from the average session volume of 801,264 shares. The stock had previously closed at GBX 8.47 ($0.11).

Scancell Stock Performance

The business’s 50-day moving average price is GBX 8.94 and its 200-day moving average price is GBX 11.77. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79. The stock has a market cap of £79.49 million, a PE ratio of -11.77 and a beta of 0.35.

Scancell (LON:SCLP) last issued its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. As a group, equities research analysts expect that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.